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The effects of intramitochondrial CaZ+ on the activities of the Ca*+-sensitive intramitochondrial enzymes, 
(i) pyruvate dehydrogenase (PDH) phosphate phosphatase, and (ii) oxoglutarate dehydrogenase (OGDH), 
were investigated in intact rat liver mitochondria by measuring (i) the amount of active PDH (PDH,) and 
(ii) the rate of decarboxylation of c(-[ 1-Yloxoglutarate (at non-saturating [oxoglutarate]), at different con- 
centrations of extramitochondrial Ca*+. In the presence of Na+ and Mg*+, both PDH and OGDH could 
be activated by increases in extramitochondrial [Ca*+] within the expected physiological range (0.05 - 5 PM). 
When liver mitochondria were prepared from rats treated with adrenaline, and then incubated in Na-free 
media containing EGTA, both PDH and OGDH activities were found to be enhanced. Evidence is present- 
ed that the activation of these nzymes by adrenaline isbrought about by a mechanism involving increases 
in intramitochondrial [Ca*+]. 
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1. INTRODUCTION 
In mammals there are three intramitochondrial 
enzymes that occupy key regulatory sites in ox- 
idative metabolism which can be activated by Ca2+ 
in the range 0.1-10 pM. They are pyruvate 
dehydrogenase (PDH), phosphate phosphatase [l] 
(whose activation increases amounts of active 
PDH (PDH.)), NAD+-isocitrate dehydrogenase 
[2] and oxoglutarate dehydrogenase (OGDH) [3]. 
Studies on rat heart [4-61, skeletal muscle [7,8] 
and adipose tissue [9] and pig lymphocytes [lo] 
have demonstrated that these enzymes can be ac- 
tivated within mitochondria (incubated with 
physiological concentrations of Mg2+ and Na+) by 
increases in extramitochondrial [Ca”] within the 
expected physiological range [l 11. This led to the 
proposal [12,13] that hormones and other agents 
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which increase cytoplasmic [Ca2’] [l l] may 
thereby increase intramitochondrial [Ca’+] and so 
activate these enzymes. Strong evidence to support 
this view has recently been obtained in studies on 
,&adrenergic agonist activation of rat heart PDH 
and OGDH [14,15]. 
In liver it is known that several hormones which 
increase cytoplasmic [Ca’+] (such as adrenaline, 
vasopressin, angiotensin and glucagon [ 16- 181) 
also cause increases in PDH, [ 19,201. There is also 
indirect evidence that OGDH is activated [21-241. 
However, other workers have argued that liver in- 
tramitochondrial [Ca”] is too high to regulate 
these enzymes [25-271 and moreover, that 
mitochondrial calcium is decreased by these Ca- 
mobilising hormones [28-3 11. 
The present study outlines methods whereby the 
Ca2+-sensitive properties of PDH phosphate 
phosphatase and OGDH can be investigated within 
liver mitochondria. These techniques were used (i) 
to study the effects of changes in extramitochon- 
drial [Ca2+] (especially within the physiological 
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range) on the enzymes activities and (ii) to examine 
the possibility that the increases in liver PDH, 
which can be brought about by the administration 
of adrenaline in vivo are the result of the hormone 
causing increases in intramitochondrial [Ca”]. 
2. MATERIALS AND METHODS 
For the experiments hown in fig.1, mitochon- 
dria were prepared from livers of fed female rats 
(approx. 250 g) which had been anaesthetised with 
0.25 ml Sagatal, by modifying the method used by 
Belsham et al. [32] to prepare adipose tissue 
mitochondria. For one rat, about ten 1 g (approx.) 
pieces of liver were each homogenised in 5 ml of 
(ice-cold) 250 mM sucrose, 20 mM Tris (pH 7.4), 
2 mM EGTA and 1% albumin (largely defatted) 
(medium A) by disruption with a precooled 
polytron probe (two bursts of 2 s at Mark 4). The 
homogenate was diluted with medium A to about 
100 ml and centrifuged in two tubes at 1000 x g for 
90 s; the mitochondria were then sedimented from 
the supernatant at 10000 x g (5 min). Each pellet 
was suspended in 6 ml of medium A with no 
albumin (medium B), 1.4 ml of Percoll was added 
and mito~hondria sedimented at 10000 x g 
(10 min). Mitochondria were washed once in 
medium B and then suspended in medium B to give 
40-80 mg protein/ml. Approx. 150 mg protein 
was obtained from each liver, corresponding (on 
the basis of total PDH activity) to a yield of 
25-35%. 
The procedure used for the experiments de- 
scribed in table 1 (effects of adrenaline) was as 
above except hat only three (approx. 1 g) pieces of 
liver (from different lobes) were rapidly removed 
and quickly homogenised (taking lo-15 s per rat) 
in 8 ml of medium A. Also in these experiments 
(table 1) a small piece of tissue from a fourth lobe 
was rapidly frozen in liquid N2 for subsequent 
analysis of tissue PDH, content. 
Table I 
The activation, as a result of adrenaline administration in vivo, of rat liver PDH and OGDH in subsequently prepared 
and incubated mitochondria; evidence that a rise in intramitochondrial [Ca2’] is involved 
Sample Additions to basic 
incubation media 
(a) PDHa (as % of total 
activity) in liver tissue or 
mitochondria from rats 
injected with 
Saline Adrenaline (n) 
(controi) 
(b) Rate of decarboxylation of 
a-[ l-‘4C]oxoglutarate at 
50fiM oxoglutarate (as % of 
rate at 2 mM oxoglutarate) by 
mitochondria from rats 
injected with 
Saline Adrenaline (n) 
(control) 
Frozen tissue - 5.6 f 1.2 14.5 k 2.9” (3) - - 
Freshly prepared 
mitochondria - 17.9 +- 3.9 27.7 f 4.5 (5) - - 
Incubated 
mitochondria 10 mM KC1 (control) 12.6 it 1.3 20.3 + 2.3’ (6) 8.4 + 0.9 13.0 Z!Z l.ob (9) 
10 mM NaCl 13.4 +: 1.8 13.9 + 1.2” (5) 7.9 k 0.8 6.9 f l.Od (9) 
10 mM KCl, 300~M Diltiazem 10.8 rt 1.2 16.9 f 1.8a (3) 9.5 f 0.7 18.9 + 2.8a (4) 
10 mM NaCl,3~~M Diltiazem 13.8 k 2.0 22.2 + 3.0a (5) 9.5 f 0.9 16.4 + 1.9b (7) 
4 mM EGTA - Ca (final 
[Ca’“] ~400 nM) 48.9 rt. 4.6 50.4 -t 6.4 (3) 34.8 rl: 2.0 32.3 rt 2.9 (7) 
Anaesthetised rats were injected intraperitoneally with either 0.3 ml saline (control) or 0.25 mg adrenaline (tartrate) in 
0.3 ml saline. After 2 min, mitochondria and tissue were prepared and then analysed as described in section 2. 
Mitochondria were incubated as described in section 2, in Medium C containing 0.5 mM EGTA and other additions 
as indicated. Results are given as means f SE for (n) rats. a P ,< 0.05 and b P $0.01 for the effects of adrenaline and 
’ P < 0.05 and d P < 0.001 for the effects of Na+ when compared to the appropriate control values by the Student’s 
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Mitochondria were incubated (at l-2 mg pro- 
tein/ml and 30°C) in 125 mM KCI, 20 mM Tris 
(pH 7.3) and 5 mM K phosphate (medium C). 
When PDH was to be measured 2 mM ox- 
oglutarate, 0.2 mM malate and 1 mM pyruvate (K- 
salts) were also present and after 5 min mitochon- 
dria (in 1 ml of medium) were harvested and 
analysed for both PDH, and total PDH content as 
in [33] (as were tissue samples), and results are 
given as % of total enzyme existing as PDH,; total 
PDH was unchanged by the treatments used and 
was between 40 and 70 munits/mg of mitochon- 
drial protein or between 1.7 and 2.4 units/g wet wt 
of tissue (where a unit forms 1 pmol acetyl 
CoA/min at 30°C). For OGDH, after a 5 min pre- 
incubation, 50pM (non-saturating) or 2 mM 
(saturating) oxoglutarate containing a suitable 
amount of ~-[l-‘4C!]oxoglutarate was added to 
100 ~1 of mitochondrial suspension in a small test- 
tube (surrounded by 0.5 ml 2-phenylethylamine) 
within a sealed scintillation vial, followed 2.5 min 
later by 50~1 of 20% perchloric acid. The rate of 
i4C02 production at 50pM oxoglutarate is ex- 
pressed as a % of that at 2 mM oxoglutarate: this 
latter rate was unchanged by the treatments used 
and was between 6 and 9 nmol/min per mg pro- 
tein; similar results to those shown were obtained 
if 0.5 mM malate was present throughout (not 
shown). It should also be noted that essentially 
similar results for both enzymes were obtained if 
mitochondrial incubations were continued for a 
further 5 min (not shown). Any other additions are 
indicated in the figure and table legends. 
The sources of all the materials used are given in 
1151. 
3. RESULTS 
3.1. Activation of PDH and OGDH in intact liver 
mito~hondria by increases in extra- 
mitochondrial [Cd’] 
When intact rat heart [4,5], skeletal muscle [7,8] 
or adipose tissue [9] mitochondria are incubated 
(at 25 or 30°C) in KCl-based medium containing 
phosphate and respiratory substrates (e.g., ox- 
oglutarate with malate) the effects of in- 
tramitochondrial [Ca”] on PDH phosphate 
phosphatase can be assayed indirectly by following 
increases in steady-state PDH, content as the ex- 
tramitochondrial [Ca’*] is increased. With intact 
liver mitochondria (fig.1) it was found to be also 
necessary to add some pyruvate (1 mM) to inhibit 
PDH, kinase (see 1331) otherwise PDH, values 
were very low and the effects of Ca2’ were small 
and difficult to observe. This is analogous to the 
situation with heart mitochondria from starved or 
diabetic rats [33] and presumably means that in the 
absence of pyruvate the kinase activity is far 
greater than that of the phosphatase f33]. It should 
be noted that mitochondrial ATP content was not 
altered by Ca’+ in the PDH experiments of fig.1 
(not shown). 
Ca2+ activates OGDH from liver and other 
mammalian tissues by decreasing its &, value for 
oxoglutarate [3,12]. The Ca2+-sensitive properties 
of OGDH within liver mitochondria (incubated in 
the absence of ADP) can be demonstrated by 
following the production of 14C02 from a non- 
saturating concentration of ~-[l-‘4C]oxoglutarate 
(fig. 1). 
Fig. 1 shows that in the presence of Mg2+ (which 
inhibits mitochondrial Ca2+ uptake [25]) and Na” 
(which stimulates egress [25]), both PDH and 
OGDH can be activated within liver mitochondria 
by increases in extramitochondrial [Ca2’] within 
the expected physiological range [1 11. These effects 
of Ca2+ can be blocked by ruthenium red, a potent 
inhibitor of Ca2+ uptake 1251. In the absence of 
Na+ and Mg2+ the activation curves are shifted to 
the left (fig. 1) as with heart [4] or adipose tissue [9] 
but the shift is less, presumably because in liver 
mitochondria Na+-dependent egress of Ca2+ is 
slower, and Na+-independent egress faster, com- 
pared to these others [25]. 
3.2. Enhancement of PDH and GGDH activities 
in liver mitochondria prepared from 
adrenaline-treated rats; evidence that 
increases in intramitochondriai /Cd’_l are 
in valved 
The ability to assay the Ca’+-sensitive properties 
of PDH and OGDH within intact liver mitochon- 
dria allowed a test to be made of the hypothesis 
f 12,131 that hormones which increase cytoplasmic 
[Ca2’] in liver (see [16-181) could thereby increase 
intramitochondrial [Ca2’] and so cause the in- 
creases in PDH, which are known to be brought 
about by these same hormones [19,20]. This was 
done by following the procedures developed to 
demonstrate that adrenaline increases in- 
261 
Volume 180, number 2 FEBS LETTERS 
60 
50 
40 
30 
20 
IO 
0 c 
iiq 
0.001 0.01 0.1 1.0 IO 100 
expected physiological range 
[ Ca2+ 1 (PM) in ext ramitochondrial i ncubat ion media 
Fig. 1. The effects of different extramitochondrial [Ca”] on ( q , n ) the PDH, content of, and (0, l ) the rate of r4C02 
production from a non-saturating concentration of cr-[1-r4C]oxoglutarate by rat liver mitochondria in the absence 
( q , 0) or presence (m, l ) of 10 mM NaCl and 1 mM MgC12. Mitochondria were incubated as described in section 2 
(and above) together with the required amounts of EGTA. Ca buffers (at 5 mM EGTA) to give the indicated [Ca”]. 
Each point and error bar is a mean f SE of observations made on at least three different preparations of mitochondria. 
Calculated KO.S values (nM) + SD for the effects of Ca2+ (for the number of degrees of freedom in parentheses) were 
(0) 112 + 40 (26), (0) 96 + 14 (26), (m) 499 f 69 (44) and (0) 586 + 92 (29). 
tramitochondrial [Ca”] in rat heart [15] and in- about 70% of its maximal effect on PDH or 
volves the rapid preparation of mitochondria from OGDH and re-isolated, it was found that these 
control and treated tissues. However, as this ap- Ca2+-dependent activations persisted through the 
proach relies on assays of Ca’+-sensitive nzymes ‘re-preparation’ of the mitochondria and their 
within subsequently incubated mitochondria as in- subsequent incubation (in media containing EGTA 
dicators for changes in intramitochondrial [Ca’+], at 3O”C), providing that Na+ was not present. 
it is first of all necessary to assess its feasibility by These persistent activations were rapidly lost (by 
examining the behaviour of PDH and OGDH 5 min) if Na+, or enough extramitochondrial 
within mitochondria loaded in vitro with Ca2+ and [Ca’+] to saturate the Ca”-dependent effects on 
then ‘re-prepared’ (again as in [15]). The results of the enzymes, was added to the incubations. 
these experiments, which are not given here, were Moreover, the effects of Na+ could be blocked by 
as follows. Briefly, if liver mitochondria were in- Diltiazem which is known to inhibit Na/Ca ex- 
cubated (as in fig.1) with enough Ca2+ to cause change in heart mitochondria [34]. In a similar 
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series of preliminary experiments (again based on 
those in [15]) liver mitochondria were re-isolated 
after loading with 45Ca under conditions where 
about 70% of the Cat+-dependent stimulation of 
PDH and OGDH was observed. When these 
mitochondria were incubated subsequently, it was 
found that very little 45Ca was lost at 0°C (< 10% 
over 2 h, re. mitochondrial preparation) or at 
30°C (< 10% in 5 min), providing Na+ was absent. 
At 3O”C, Na+ rapidly reduced mitochondrial 45Ca 
content (by about 50% in 5 min) unless Diltiazem 
was also present. 
The effects of the in vivo administration of 
adrenaline on the activities of PDH and OGDH 
within subsequently prepared and incubated liver 
mitochondria are presented in table 1. In the 
absence of Na+, both activities were increased 
about 2-fold in mitochondria from adrenaline- 
treated rats compared to controls, even after 5 min 
incubation at 30°C in the presence of EGTA. 
These effects were lost if Na+ was present, but not 
when Diltiazem was also present, suggesting that 
Na+ acts by stimulating the efflux of Ca2+ from 
the mitochondria. The effects could be lost by in- 
creasing extramitochondrial [Ca’+] to about 
400 nM, presumably because this leads (in the 
absence of Na+ and Mg2+) to maximal 
Ca’+-dependent activation of these enzymes (see 
fig.1). It should be noted that, under the condi- 
tions used, the mitochondrial ATP and NAD(P)H 
contents are unchanged or even increased as the 
result of adrenaline treatment (not shown). 
4. DISCUSSION 
The results of the present study are consistent 
with increases in liver intramitochondrial [Ca”] 
being responsible for the activations of PDH and 
OGDH by adrenaline and may thus form part of 
the mechanism whereby adrenaline and other Ca- 
mobilising hormones stimulate oxidative 
metabolism in the liver (see [35]). The results are 
also in accord with the recent proposals that Ca- 
mobilising hormones stimulate the production of 
myo-inositol 1,4,5_trisphosphate which then 
releases Ca2+ from pools in the endoplasmic 
reticulum [36,37]. However, they are not in accord 
with the measurement of a decrease in the total 
calcium content of mitochondrial fractions caused 
by these hormones and the consequent hypothesis 
that they increase cytoplasmic [Ca2+] by eliciting 
mitochondrial Ca2+ release by an unknown 
mechanism [27-3 1,381. A possible explanation for 
these latter observations is that mitochondrial frac- 
tions were contaminated with the hormonally- 
sensitive reticulum fraction which will have lost 
Ca*+ following hormone treatment. It is of interest 
that when 45Ca is used to assess the calcium con- 
tent of mitochondrial fractions, an increase is 
observed following hormone treatment [39,40]. 
The present study should avoid contamination 
problems because exclusively intramitochondrial 
parameters have been measured, although there re- 
mains the possibility that hormones may alter rela- 
tionships between free and total Ca pools in the 
mitochondria. Finally, the present results further 
support the concept that under normal 
physiological conditions the Ca’+-transport 
systems of the mitochondrial inner membrane xist 
primarily to relay changes in cytoplasmic [Ca*+] to 
the mitochondrial matrix [12,13] rather than, con- 
versely, to ‘buffer’ or ‘set’ cytoplasmic [Ca2+] 
[25,41]. 
In female rats, adrenaline probably brings about 
its effects on liver by acting through both a- (i.e., 
Ca2+-mediated) and ,&- (i.e., cyclic AMP-mediated) 
adrenergic receptor stimulation [42]. However, it is 
clear that adrenaline does cause a rise in 
cytoplasmic [Ca2’] in the liver of female rats [42] 
and it is also becoming evident that @receptor 
stimulation may also lead to increases in 
cytoplasmic [Ca2’] [16,42]. At any rate, essentially 
similar results to those given in table 1 were ob- 
tained with male rats (about 200-250 g) (not 
shown) where adrenaline appears to act virtually 
exclusively through a-receptors [42]. 
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